Frontiers in Molecular Neuroscience,
Journal Year:
2024,
Volume and Issue:
16
Published: Jan. 5, 2024
Amyotrophic
Lateral
Sclerosis
(ALS)
and
Frontotemporal
Dementia
(FTD)
are
debilitating
neurodegenerative
diseases
with
shared
pathological
features
like
transactive
response
DNA-binding
protein
of
43
kDa
(TDP-43)
inclusions
genetic
mutations.
Both
involve
synaptic
dysfunction,
contributing
to
their
clinical
features.
Synaptic
biomarkers,
representing
proteins
associated
function
or
structure,
offer
insights
into
disease
mechanisms,
progression,
treatment
responses.
These
biomarkers
can
detect
early,
track
its
evaluate
therapeutic
efficacy.
ALS
is
characterized
by
elevated
neurofilament
light
chain
(NfL)
levels
in
cerebrospinal
fluid
(CSF)
blood,
correlating
progression.
TDP-43
another
key
biomarker,
mislocalization
linked
dysfunction.
In
FTD,
tau
studied
as
biomarkers.
neuronal
pentraxins
(NPs),
including
pentraxin
2
(NPTX2),
receptor
(NPTXR),
FTD
pathology
cognitive
decline.
Advanced
technologies,
machine
learning
(ML)
artificial
intelligence
(AI),
aid
biomarker
discovery
drug
development.
Challenges
this
research
include
technological
limitations
detection,
variability
across
patients,
translating
findings
from
animal
models.
ML/AI
accelerate
analyzing
complex
data
predicting
outcomes.
early
personalized
strategies,
mechanisms.
While
challenges
persist,
advancements
interdisciplinary
efforts
promise
revolutionize
the
understanding
management
FTD.
This
review
will
explore
present
comprehension
discuss
significance
emphasize
prospects
obstacles.
ABSTRACT
Induced
pluripotent
stem
cell
(iPSC)
technologies
have
provided
in
vitro
models
of
inaccessible
human
types,
yielding
new
insights
into
disease
mechanisms
especially
for
neurological
disorders.
However,
without
due
consideration,
the
thousands
iPSC
lines
generated
past
decade
will
inevitably
affect
reproducibility
iPSC-based
experiments.
Differences
between
donor
individuals,
genetic
stability
and
experimental
variability
contribute
to
model
variation
by
impacting
differentiation
potency,
cellular
heterogeneity,
morphology,
transcript
protein
abundance.
Such
effects
confound
reproducible
modelling
absence
appropriate
strategies.
In
this
Review,
we
explore
causes
propose
approaches
detect
account
studies,
or
even
exploit
it
deeper
biological
insight.
Antioxidants,
Journal Year:
2020,
Volume and Issue:
9(6), P. 492 - 492
Published: June 5, 2020
Cadmium
(Cd),
a
category
I
human
carcinogen,
is
well-known
widespread
environmental
pollutant.
Chronic
Cd
exposure
affects
different
organs
and
tissues,
such
as
the
central
nervous
system
(CNS),
its
deleterious
effects
can
be
linked
to
indirect
reactive
oxygen
species
(ROS)
generation.
Since
predominantly
present
in
+2
oxidation
state,
it
interplay
with
plethora
of
channels
transporters
cell
membrane
surface
order
enter
cells.
Mitochondrial
dysfunction,
ROS
production,
glutathione
depletion
lipid
peroxidation
are
reviewed
better
characterize
Cd-elicited
molecular
pathways.
Furthermore,
on
CNS
types
have
been
highlighted
elucidate
role
neurodegenerative
disorders.
Indeed,
increase
blood-brain
barrier
(BBB)
permeability
promotes
entry
that,
turn,
stimulates
pericytes
maintaining
BBB
open.
Once
inside
CNS,
acts
glial
cells
(astrocytes,
microglia,
oligodendrocytes)
triggering
pro-inflammatory
cascade
that
accounts
for
neurons
inducing
destruction
synaptic
branches.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(21), P. 12841 - 12841
Published: Oct. 25, 2022
Alzheimer’s
disease
(AD)
is
the
leading
cause
of
dementia
in
elderly
people.
Amyloid
beta
(Aβ)
deposits
and
neurofibrillary
tangles
are
major
pathological
features
an
brain.
These
proteins
highly
expressed
nerve
cells
found
most
tissues.
Tau
primarily
provides
stabilization
to
microtubules
part
axons
dendrites.
However,
tau
a
state
becomes
hyperphosphorylated,
causing
dysfunction
synaptic
impairment
degeneration
neurons.
This
article
presents
summary
role
tau,
phosphorylated
(p-tau)
AD,
other
tauopathies.
Tauopathies,
including
Pick’s
disease,
frontotemporal
dementia,
corticobasal
degeneration,
argyrophilic
grain
progressive
supranuclear
palsy,
Huntington’s
result
misprocessing
accumulation
within
neuronal
glial
cells.
also
focuses
on
current
research
post-translational
modifications
genetics
pathology,
tauopathies
development
new
drugs
targeting
p-tau,
therapeutics
for
treating
possibly
preventing
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(4), P. 972 - 972
Published: Feb. 15, 2023
It
has
been
reported
that
disordered
Cu
metabolism
is
associated
with
several
neurodegenerative
diseases,
including
Alzheimer's
disease
(AD)
and
Parkinson's
(PD).
However,
the
underlying
mechanism
still
unclear.
In
this
study,
4-week-old
male
mice
were
exposed
to
by
free-drinking
water
for
three
months.
Then,
effects
of
on
cognitive
functions
in
tested
Morris
maze
tests,
potential
mechanisms
investigated
ELISA,
immunochemistry,
TUNEL,
Western
blot
tests.
was
found
exacerbates
learning
memory
impairment,
leads
Cu-overload
brain
urine
mice.
The
results
showed
induces
neuronal
degeneration
oxidative
damage,
promotes
expression
apoptosis-related
protein
Bax,
cuproptosis-related
proteins
FDX1
DLAT
proteotoxic
stress
marker
HSP70,
decreases
Fe-S
cluster
proteins.
addition,
affects
pre-synaptic
post-synaptic
regulatory
through
inhibiting
PSD-95
SYP.
also
suppresses
phosphorylation
levels
CREB
BDNF
TrkB
mouse
hippocampus.
conclusion,
might
mediate
cuproptosis,
damage
synaptic
plasticity
inhibit
CREB/BDNF
pathway
cause
dysfunction
Biomarker Insights,
Journal Year:
2020,
Volume and Issue:
15, P. 117727192095031 - 117727192095031
Published: Jan. 1, 2020
Synapses
are
the
site
for
brain
communication
where
information
is
transmitted
between
neurons
and
stored
memory
formation.
Synaptic
degeneration
a
global
early
pathogenic
event
in
neurodegenerative
disorders
with
reduced
levels
of
pre-
postsynaptic
proteins
being
recognized
as
core
feature
Alzheimer’s
disease
(AD)
pathophysiology.
Together
AD,
other
neurodevelopmental
show
altered
synaptic
homeostasis
an
important
event,
due
to
that,
they
commonly
referred
synaptopathies.
The
exact
mechanisms
synapse
dysfunction
different
diseases
not
well
understood
their
study
would
help
understanding
role
degeneration,
differences
commonalities
among
them
highlight
candidate
biomarkers
specific
disorders.
assessment
cerebrospinal
fluid
(CSF),
which
can
reflect
patients
cognitive
disorders,
keen
area
interest.
Substantial
research
efforts
now
directed
toward
investigation
CSF
pathology
improve
diagnosis
at
stage
monitor
clinical
progression.
In
this
review,
we
will
first
summarize
pathological
events
that
lead
loss
then
discuss
available
data
on
established
(eg,
neurogranin,
SNAP-25,
synaptotagmin-1,
GAP-43,
α-syn)
emerging
vesicle
glycoprotein
2A
neuronal
pentraxins)
dysfunction,
while
highlighting
possible
utilities,
specificity,
technical
challenges
detection.
Frontiers in Aging Neuroscience,
Journal Year:
2021,
Volume and Issue:
13
Published: Oct. 20, 2021
Structural
and
functional
integrity
of
the
cerebral
vasculature
ensures
proper
brain
development
function,
as
well
healthy
aging.
The
inability
to
store
energy
makes
it
exceptionally
dependent
on
an
adequate
supply
oxygen
nutrients
from
blood
stream
for
matching
colossal
demands
neural
glial
cells.
Key
vascular
features
including
a
dense
vasculature,
tightly
controlled
environment,
regulation
flow
(CBF)
all
take
part
in
health
throughout
life.
As
such,
aging
are
both
ensured
by
anatomical
interaction
between
nervous
systems
that
established
during
maintained
lifespan.
During
critical
periods
development,
networks
remodel
until
they
can
actively
respond
increases
activity
through
neurovascular
coupling,
which
particularly
vulnerable
alterations.
has
been
strongly
associated
with
onset
and/or
progression
conditions
aging,
more
recently
neurodevelopmental
disorders.
Our
understanding
cerebrovascular
contributions
neurological
disorders
is
rapidly
evolving,
increasing
evidence
shows
deficits
angiogenesis,
CBF
blood-brain
barrier
(BBB)
causally
linked
cognitive
impairment.
Moreover,
utmost
curiosity
although
neurodegenerative
express
different
clinical
at
stages
life,
share
similar
abnormalities.
In
this
review,
we
present
overview
dysfunctions
(autism
spectrum
disorders,
schizophrenia,
Down
Syndrome)
(multiple
sclerosis,
Huntington’s,
Parkinson’s,
Alzheimer’s
diseases)
focus
impairments
BBB.
Finally,
discuss
impact
early
expression
diseases.
Frontiers in Neuroscience,
Journal Year:
2022,
Volume and Issue:
16
Published: March 25, 2022
The
brain
is
the
central
and
most
complex
organ
in
nervous
system,
comprising
billions
of
neurons
that
constantly
communicate
through
trillions
connections
called
synapses.
Despite
being
formed
mainly
during
prenatal
early
postnatal
development,
synapses
are
continually
refined
eliminated
throughout
life
via
complicated
hitherto
incompletely
understood
mechanisms.
Failure
to
correctly
regulate
numbers
distribution
has
been
associated
with
many
neurological
psychiatric
disorders,
including
autism,
epilepsy,
Alzheimer’s
disease,
schizophrenia.
Therefore,
measurements
synaptic
density,
as
well
detection
dysfunction,
essential
for
understanding
normal
abnormal
development.
To
date,
multiple
density
markers
have
proposed
investigated
experimental
models
disorders.
majority
gold
standard
methodologies
(e.g.,
electron
microscopy
or
immunohistochemistry)
visualize
measure
changes
pre-
postsynaptic
proteins
ex
vivo
.
However,
invasive
nature
these
classic
precludes
their
use
living
organisms.
recent
development
positron
emission
tomography
(PET)
tracers
[such
(
18
F)UCB-H
11
C)UCB-J]
bind
a
putative
marker,
vesicle
2A
(SV2A)
protein,
heralding
likely
paradigm
shift
detecting
alterations
patients.
limited
specificity,
novel,
non-invasive
magnetic
resonance
(MR)-based
methods
also
show
promise
inferring
information
by
linking
glutamate
neurotransmission.
Although
promising,
all
entail
various
advantages
limitations
must
be
addressed
before
becoming
part
routine
clinical
practice.
In
this
review,
we
summarize
discuss
current
quantifying
an
evaluation
reliability
utility.
We
conclude
critical
assessment
challenges
need
overcome
successfully
employing
biomarkers
diagnostic
and/or
prognostic
tools
study
neuropsychiatric
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(10), P. 9067 - 9067
Published: May 22, 2023
Alzheimer’s
disease
(AD)
is
a
chronic
neurodegenerative
and
the
most
frequent
cause
of
progressive
dementia
in
senior
adults.
It
characterized
by
memory
loss
cognitive
impairment
secondary
to
cholinergic
dysfunction
N-methyl-D-aspartate
(NMDA)-mediated
neurotoxicity.
Intracellular
neurofibrillary
tangles,
extracellular
plaques
composed
amyloid-β
(Aβ),
selective
neurodegeneration
are
anatomopathological
hallmarks
this
disease.
The
dysregulation
calcium
may
be
present
all
stages
AD,
it
associated
with
other
pathophysiological
mechanisms,
such
as
mitochondrial
failure,
oxidative
stress,
neuroinflammation.
Although
cytosolic
alterations
AD
not
completely
elucidated,
some
calcium-permeable
channels,
transporters,
pumps,
receptors
have
been
shown
involved
at
neuronal
glial
levels.
In
particular,
relationship
between
glutamatergic
NMDA
receptor
(NMDAR)
activity
amyloidosis
has
widely
documented.
Other
mechanisms
dyshomeostasis
include
activation
L-type
voltage-dependent
transient
potential
ryanodine
receptors,
among
many
others.
This
review
aims
update
calcium-dysregulation
discuss
targets
molecules
therapeutic
based
on
their
modulation.
Journal of Neural Transmission,
Journal Year:
2023,
Volume and Issue:
130(5), P. 627 - 646
Published: April 16, 2023
Abstract
Since
the
description
of
some
peculiar
symptoms
by
James
Parkinson
in
1817,
attempts
have
been
made
to
define
its
cause
or
at
least
enlighten
pathology
“Parkinson’s
disease
(PD).”
The
vast
majority
PD
subtypes
and
most
cases
sporadic
share
Lewy
bodies
(LBs)
as
a
characteristic
pathological
hallmark.
However,
processes
underlying
LBs
generation
causal
triggers
are
still
unknown.
ɑ-Synuclein
(ɑ-syn,
encoded
SNCA
gene)
is
major
component
LBs,
missense
mutations
duplications/triplications
for
rare
hereditary
forms
PD.
Thus,
it
imperative
study
ɑ-syn
protein
pathology,
including
oligomerization,
fibril
formation,
aggregation,
spreading
mechanisms.
Furthermore,
there
synergistic
effects
pathogenic
mechanisms
PD,
multiple
factors—contributing
with
different
ratios—appear
be
progression
factors.
For
example,
oxidative
stress,
reduced
antioxidative
capacity,
mitochondrial
dysfunction,
proteasomal
disturbances
each
suggested
formation
aggregation
contribute
neuroinflammation
neural
cell
death.
Aging
also
risk
factor
Iron,
well
neuromelanin
(NM),
show
age-dependent
increases,
iron
significantly
increased
Parkinsonian
substantia
nigra
(SN).
Iron-induced
include
changes
molecular
structure
ɑ-syn.
more
recent
research
demonstrates
that
(i)
detected
not
only
dopaminergic
neurons
glia
but
various
neurotransmitter
systems,
(ii)
sympathetic
nerve
fibres
degenerate
first,
(iii)
“brain-first”
deficiency
evident
before
induced
NM.
These
findings
support
ɑ-syn/LBs
iron-
NM-induced
important
facts
via
their
interaction
potentiate
process
SN.
As
such,
multifactorial
toxic
posted
on
personal
genetic
assumed
neurodegenerative
Differences
ratios
factors
spatiotemporal
development,
fact
common
hard
identify,
imply
existence
several
phenotypical
subtypes,
which
supported
arguments
from
both
“bottom-up/dual-hit”
models.
Therapeutic
strategies
necessary
avoid
single
initiation
leading